These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10413261)

  • 1. Seasonal allergic conjunctivitis induced by Japanese pear pollen.
    Yanagisawa S; Nagaki Y; Hiraki S; Kadoi C; Hayasaka S; Teranishi H
    Jpn J Ophthalmol; 1999; 43(3):240-2. PubMed ID: 10413261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
    Abelson MB; Turner D
    Clin Ther; 2003 Mar; 25(3):931-47. PubMed ID: 12852709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.
    Katelaris CH; Ciprandi G; Missotten L; Turner FD; Bertin D; Berdeaux G;
    Clin Ther; 2002 Oct; 24(10):1561-75. PubMed ID: 12462286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of topical mequitazine and disodium cromoglycate in allergic conjunctivitis induced by a specific conjunctival provocation test.
    Dupin O; Trinquand C; Persi L; Bousquet J; Robert F; Arnaud B
    Eur J Ophthalmol; 2000; 10(1):15-21. PubMed ID: 10744200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H; Ohashi Y; Takamura E
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y; Enomoto T; Cheng L; Enomoto K; Shibano A; Ikeda H; Yoda S; Yajin S; Sakota T; Yamanishi E
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ocular treatment with monoclonal antibody Fab fragments targeting Japanese cedar pollen Cry j 1 inhibits Japanese cedar pollen-induced allergic conjunctivitis in mice.
    Mizutani N; Nabe T; Yoshino S
    Eur J Pharmacol; 2017 Mar; 798():105-112. PubMed ID: 28119075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis.
    Blumenthal MN; Schwartz RH; Kaiser H
    Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind group comparative study of ophthalmic sodium cromoglycate, 2% four times daily and 4% twice daily, in the treatment of seasonal allergic conjunctivitis.
    Leino M; Montan P; Njå F
    Allergy; 1994 Mar; 49(3):147-51. PubMed ID: 8198246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-allergic effects of a cromolyn sodium-chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge model.
    Leonardi A; Busca F; Tavolato M; Secchi AG
    Eur J Ophthalmol; 2003 Mar; 13(2):128-33. PubMed ID: 12696630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis.
    Bilkhu PS; Wolffsohn JS; Naroo SA; Robertson L; Kennedy R
    Ophthalmology; 2014 Jan; 121(1):72-78. PubMed ID: 24070810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB; Olsen AK
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study.
    Nakatani H; Gomes P; Bradford R; Guo Q; Safyan E; Hollander DA
    Ocul Immunol Inflamm; 2019; 27(4):622-631. PubMed ID: 29543548
    [No Abstract]   [Full Text] [Related]  

  • 15. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
    Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local specific immunotherapy in allergic conjunctivitis.
    Del Prete A; Loffredo C; Carderopoli A; Caparello O; Verde R; Sebastiani A
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):631-4. PubMed ID: 7887165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
    Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
    Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.
    Dell SJ; Shulman DG; Lowry GM; Howes J
    Am J Ophthalmol; 1997 Jun; 123(6):791-7. PubMed ID: 9535623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical sodium cromoglycate (Opticrom) relieves ongoing symptoms of allergic conjunctivitis within 2 minutes.
    Montan P; Zetterström O; Eliasson E; Strömquist LH
    Allergy; 1994 Sep; 49(8):637-40. PubMed ID: 7653743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of measurement method for antigen specific IgE in tears of patients with allergic conjunctival disease].
    Kitazawa M; Shoji J; Inada N; Sawa M; Kato H
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):578-82. PubMed ID: 14598708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.